Use of cyanide antidotes in burn patients with suspected inhalation injuries in North America: A cross-sectional survey

Journal of Burn Care and Research

Volumn 35, Issue 2, 2014, Pages

  Dumestre, Danielle ^a   Nickerson, Duncan ^b  

^a FOOTHILLS HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIDOTES; BURN UNITS; CROSS-SECTIONAL STUDIES; CYANIDES; FEMALE; HUMANS; HYDROXOCOBALAMIN; MALE; NORTH AMERICA; QUESTIONNAIRES; SMOKE INHALATION INJURY;

EID: 84894425606     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e31829b3868     Document Type: Article

References (48)

1. Reade MC, Davies SR, Morley PT, Dennett J, Jacobs IC; Australian Resuscitation Council. Review article: management of cyanide poisoning. Emerg Med Australas 2012;24:225-38.
2. Anseeuw K, Delvau N, Burillo-Putze G, et al. Cyanide poisoning by fire smoke inhalation: a European expert consensus. Eur J Emerg Med 2013;20:2-9.
3. Grabowska T, Skowronek R, Nowicka J, Sybirska H. Prevalence of hydrogen cyanide and carboxyhaemoglobin in victims of smoke inhalation during enclosed-space fires: a combined toxicological risk. Clin Toxicol (Phila) 2012;50:759-63.
4. Alarie Y. Toxicity of fire smoke. Crit Rev Toxicol 2002;32:259-89.
5. Baud FJ, Barriot P, Toffis V, et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med 1991;325:1761-6.
6. Jones J, McMullen MJ, Dougherty J. Toxic smoke inhalation: cyanide poisoning in fire victims. Am J Emerg Med 1987;5:317-21.
7. Silverman SH, Purdue GF, Hunt JL, Bost RO. Cyanide toxicity in burned patients. J Trauma 1988;28:171-6.
8. Clark CJ, Campbell D, Reid WH. Blood carboxyhaemoglobin and cyanide levels in fire survivors. Lancet 1981;1:1332-5.
9. Rachinger J, Fellner FA, Stieglbauer K, Trenkler J. MR changes after acute cyanide intoxication. AJNR Am J Neuroradiol 2002;23:1398-401.
10. Eckstein M, Maniscalco PM. Focus on smoke inhalation-the most common cause of acute cyanide poisoning. Prehosp Disaster Med 2006;21:s49-55.
11. Kales SN, Christiani DC. Acute chemical emergencies. N Engl J Med 2004;350:800-8.
12. Shusterman D, Alexeeff G, Hargis C, et al. Predictors of carbon monoxide and hydrogen cyanide exposure in smoke inhalation patients. J Toxicol Clin Toxicol 1996;34: 61-71.
13. Alarie Y. The toxicity of smoke from polymeric materials during thermal decomposition. Annu Rev Pharmacol Toxicol 1985;25:325-47.
14. Hamel J. A review of acute cyanide poisoning with a treatment update. Crit Care Nurse 2011;31(1):72-81; quiz 82.
15. DesLauriers CA, Burda AM, Wahl M. Hydroxocobalamin as a cyanide antidote. Am J Ther 2006;13:161-5.
16. Gracia R, Shepherd G. Cyanide poisoning and its treatment. Pharmacotherapy 2004;24:1358-65.
17. Lawson-Smith P, Jansen EC, Hyldegaard O. Cyanide intoxication as part of smoke inhalation-a review on diagnosis and treatment from the emergency perspective. Scand J Trauma Resusc Emerg Med 2011;19:14.
18. Vogel SN, Sultan TR, Ten Eyck RP. Cyanide poisoning. Clin Toxicol 1981;18:367-83.
19. Mégarbane B, Delahaye A, Goldgran-Tolédano D, Baud FJ. Antidotal treatment of cyanide poisoning. J Chin Med Assoc 2003;66:193-203.
20. Fortin JL, Desmettre T, Manzon C, et al. Cyanide poisoning and cardiac disorders: 161 cases. J Emerg Med 2010;38:467-76.
21. Goh SH, Tiah L, Lim HC, Ng EK. Disaster preparedness: Experience from a smoke inhalation mass casualty incident. Eur J Emerg Med 2006;13:330-4.
22. Kirk MA, Gerace R, Kulig KW. Cyanide and methemoglobin kinetics in smoke inhalation victims treated with the cyanide antidote kit. Ann Emerg Med 1993;22:1413-8.
23. Baud FJ, Borron SW, Mégarbane B, et al. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med 2002;30:2044-50.
24. Baud FJ. Cyanide: critical issues in diagnosis and treatment. Hum Exp Toxicol 2007;26:191-201.
25. Strickland A, Wang RY, Hoffman RS, Goldfrank LR. Blood cyanide concentrations after smoke inhalation. N Engl J Med 1992;326:1362.
26. Alcorta R. Smoke inhalation & acute cyanide poisoning. Hydrogen cyanide poisoning proves increasingly common in smoke-inhalation victims. JEMS. 2004;29(8):suppl 6-15; quiz suppl 16-17.
27. Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 2007;49(6):794-801, 801 e791-2.
28. Borron SW, Baud FJ, Mégarbane B, Bismuth C. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med 2007;25: 551-8.
29. Rehberg S, Maybauer MO, Enkhbaatar P, Maybauer DM, Yamamoto Y, Traber DL. Pathophysiology, management and treatment of smoke inhalation injury. Expert Rev Respir Med 2009;3:283-97.
30. O'Brien DJ, Walsh DW, Terriff CM, Hall AH. Empiric management of cyanide toxicity associated with smoke inhalation. Prehosp Disaster Med 2011;26:374-82.
31. Lavon O, Bentur Y. Does amyl nitrite have a role in the management of pre-hospital mass casualty cyanide poisoning? Clin Toxicol (Phila) 2010;48:477-84.
32. Becker CE. The role of cyanide in fires. Vet Hum Toxicol 1985;27:487-90.
33. Hall AH, Kulig KW, Rumack BH. Suspected cyanide poisoning in smoke inhalation: complications of sodium nitrite therapy. J Toxicol Clin Exp 1989;9:3-9.
34. Hall AH, Saiers J, Baud F. Which cyanide antidote? Crit Rev Toxicol 2009;39:541-52.
35. Bebarta VS, Pitotti RL, Dixon P, Lairet JR, Bush A, Tanen DA. Hydroxocobalamin versus sodium thiosulfate for the treatment of acute cyanide toxicity in a swine (Sus scrofa) model. Ann Emerg Med 2012;59:532-9.
36. Hall AH, Dart R, Bogdan G. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? Ann Emerg Med 2007;49:806-13.
37. Fortin JL, Giocanti JP, Ruttimann M, Kowalski JJ. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol (Phila) 2006;44(Suppl 1):37-44.
38. Uhl W, Nolting A, Golor G, Rost KL, Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol (Phila) 2006;44(Suppl 1):17-28.
39. Uhl W, Nolting A, Gallemann D, Hecht S, Kovar A. Changes in blood pressure after administration of hydroxocobalamin: relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers. Clin Toxicol (Phila). 2008;46(6):551-9; discussion 576-57.
40. Houeto P, Hoffman JR, Imbert M, Levillain P, Baud FJ. Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxocobalamin in cyanide poisoning. Lancet 1995;346:605-8.
41. Gerth K, Ehring T, Braendle M, Schelling P. Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile. Clin Toxicol (Phila) 2006;44(Suppl 1):29-36.
42. Shepherd G, Velez LI. Role of hydroxocobalamin in acute cyanide poisoning. Ann Pharmacother 2008;42:661-9.
43. Forsyth JC, Mueller PD, Becker CE, et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 1993;31:277-94.
44. Livshits Z, Lugassy DM, Shawn LK, Hoffman RS. Falsely low carboxyhemoglobin level after hydroxocobalamin therapy. N Engl J Med 2012;367:1270-1.
45. Hudson M, Cashin BV, Matlock AG, Kang C, Wills BK. A man with purple urine. Hydroxocobalamin-induced chromaturia. Clin Toxicol (Phila) 2012;50:77.
46. Geraci MJ, McCoy SL, Aquino ME. Woman with red urine: hydroxocobalamin-induced chromaturia. J Emerg Med 2012;43:e207-9.
47. Dart RC, Borron SW, Caravati EM, et al. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med 2009;54(3):386-394 e381.
48. Woodson LC. Diagnosis and grading of inhalation injury. J Burn Care Res 2009;30:143-5.